Systemic Sclerosis
📧 Sign up to get email alerts when something new happens for Systemic Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-27Clinical Trial Update: Pregnancy and Medically Assisted Conception in Rare Diseases
Clinical trial NCT02450396 on pregnancy and medically assisted conception in rare autoimmune diseases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-03-05Clinical Trial Update: A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases [Phase 1]
A Phase 1 study evaluating CLBR001 and SWI019 in autoimmune diseases has been withdrawn from further development.
-
CLINICAL_TRIALS withdrawal · 2026-02-03Clinical Trial Update: A Study of RD06-04 in Patients With Active Autoimmune Diseases [EARLY_Phase 1]
A early Phase 1 study of RD06-04 in active autoimmune diseases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-08Clinical Trial Update: Clinical Usefulness and Influence on Esophageal Motility of Pyridostigmine for Dysphagia in Systemic Sclerosis [Phase 2]
A Phase 2 trial of pyridostigmine for dysphagia in systemic sclerosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-06Clinical Trial Update: A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc) [Phase 1]
A Phase 1 study of TAK-007 in adults with refractory lupus nephritis or refractory systemic sclerosis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-02-20Clinical Trial Update: CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating comprehensive phenotypic characterization of patients with scleroderma-associated interstitial lung disea…
-
CLINICAL_TRIALS withdrawal · 2025-02-04Clinical Trial Update: RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis [Phase 1]
A Phase 1 trial evaluating reduced-intensity conditioning allogeneic bone marrow transplant with post-transplant cyclophosphamide for refrac…
-
CLINICAL_TRIALS withdrawal · 2020-06-30Clinical Trial Update: Intraoperative ICG for Systemic Sclerosis [Phase 4]
Phase 4 clinical trial investigating intraoperative ICG for systemic sclerosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-22Clinical Trial Update: Probiotics in Patients With Moderate-to-severe Distention/ Bloating From Systemic Sclerosis [Phase 4]
The Phase 4 trial evaluating probiotics for moderate-to-severe distention and bloating in systemic sclerosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-11Clinical Trial Update: Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma [Phase 1, Phase 2]
The clinical trial evaluating divalproex sodium for the cutaneous manifestations of systemic sclerosis (scleroderma) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-22Clinical Trial Update: A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) [Phase 2]
A Phase 2 double-blind trial evaluating BMS-986020 versus placebo in diffuse cutaneous systemic sclerosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-17Clinical Trial Update: Scleroderma Treatment With Celution Processed ADRCs Registry
A clinical trial evaluating Celution-processed adipose-derived regenerative cells (ADRCs) for systemic sclerosis has been withdrawn from the…
-
CLINICAL_TRIALS withdrawal · 2015-12-02Clinical Trial Update: Evaluating Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis [NA]
A clinical trial evaluating pulmonary arterial hypertension in patients with systemic sclerosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-12-02Clinical Trial Update: Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc) [NA]
A clinical trial evaluating pulmonary Doppler signals in patients with Systemic Sclerosis and Pulmonary Hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-02Clinical Trial Update: Systemic Sclerosis Clinical and Biomarker Study
Biogen's Systemic Sclerosis clinical and biomarker study has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-08Clinical Trial Update: Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients
A clinical trial investigating stress echocardiography to detect pulmonary arterial hypertension in systemic sclerosis patients has been wit…
-
CLINICAL_TRIALS withdrawal · 2012-10-31Clinical Trial Update: Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis [Phase 2]
A Phase 2 trial evaluating low-dose conditioning followed by donor stem cell transplantation for severe systemic sclerosis has been withdraw…